71 related articles for article (PubMed ID: 6671715)
21. [Killer T cell activity specific to Epstein-Barr virus in patients with uterine cervical cancer].
Kitano Y; Fujisaki S; Okamura H
Nihon Sanka Fujinka Gakkai Zasshi; 1988 May; 40(5):647-8. PubMed ID: 2838557
[No Abstract] [Full Text] [Related]
22. Oncolytic activity of NK cells against SW-756 squamous cervical carcinoma cell line: role of interferons alpha and gamma and CD54 adhesion molecule in oncolysis.
Cristoforoni PM; Lotzová E; Cook KR; Chuang LT; Morris M; Grossi CE; Wharton JT
Gynecol Oncol; 1994 Mar; 52(3):365-72. PubMed ID: 7512522
[TBL] [Abstract][Full Text] [Related]
23. [Genital herpes and cervical cancer].
Grebeniuk BN; Shuvaeva NI; Grigor'ev VV; Posevaia TA; Shubladze AK
Vestn Dermatol Venerol; 1981 Feb; (2):9-12. PubMed ID: 6261479
[No Abstract] [Full Text] [Related]
24. Natural killer cell cytotoxicity in the peripheral blood, cervical lymph nodes, and tumor of head and neck cancer patients.
Mickel RA; Kessler DJ; Taylor JM; Lichtenstein A
Cancer Res; 1988 Sep; 48(17):5017-22. PubMed ID: 3409231
[TBL] [Abstract][Full Text] [Related]
25. Interleukin 2 and alpha interferon induced in vitro modulation of spontaneous cell mediated cytotoxicity in patients with cancer of the uterine cervix undergoing radiotherapy.
Radhakrishna Pillai M; Balaram P; Padmanabhan TK; Abraham T; Krishnan Nair M
Acta Oncol; 1989; 28(1):39-44. PubMed ID: 2784974
[TBL] [Abstract][Full Text] [Related]
26. [Detection of herpes simplex virus antigen in human cervical carcinoma tissue].
Xu ZH
Zhonghua Fu Chan Ke Za Zhi; 1986 Jul; 21(4):238-41, 254. PubMed ID: 3021401
[No Abstract] [Full Text] [Related]
27. [Natural cytotoxicity of peripheral blood mononuclear cells in Herpes simplex and Varicella-zoster virus infections].
Leszczyszyn-Pynka M
Acta Haematol Pol; 1995; 26(4):393-402. PubMed ID: 8571741
[TBL] [Abstract][Full Text] [Related]
28. Letter: Cell mediated response to herpes simplex virion and non-virion antigens in patients with cervical carcinoma with a depressed response to phytohemagglutinin.
Sprecher-Golberger S; Thiry L; de Halleux F; Bossens M; Gould I
Biomedicine; 1975 Nov; 23(9):399-401. PubMed ID: 182294
[No Abstract] [Full Text] [Related]
29. Antibody-dependent cell mediated cytotoxicity against nucleated target cells in patients with squamous cell carcinoma of uterine cervix.
Bose M; Seth P; Pothen S; Sharma LK; Ghosh D
Indian J Med Res; 1985 May; 81():488-92. PubMed ID: 4030033
[No Abstract] [Full Text] [Related]
30. Influence of menstrual cycle variations on natural killer cytotoxicity and antibody-dependent cellular cytotoxicity to cells infected with herpes simplex virus.
Gonik B; Loo LS; Bigelow R; Kohl S
J Reprod Med; 1985 Jun; 30(6):493-6. PubMed ID: 4020792
[TBL] [Abstract][Full Text] [Related]
31. Natural killer cytotoxicity and antibody dependent cellular cytotoxicity in human herpes simplex virus infection.
Hristescu S; Sahnazarov N; Muţiu A; Olinescu A
Arch Roum Pathol Exp Microbiol; 1987; 46(4):333-46. PubMed ID: 2845886
[No Abstract] [Full Text] [Related]
32. Cellular cytotoxicity to herpes simplex virus-infected cells of leukocytes from patients with serious burns.
Kohl S; Ericsson CD
Clin Immunol Immunopathol; 1982 Aug; 24(2):171-8. PubMed ID: 7116698
[No Abstract] [Full Text] [Related]
33. Cell-mediated cytotoxicity in preinvasive and invasive squamous cell carcinoma of the cervix.
Dini MM; Jafari K; Faiferman I
Obstet Gynecol; 1980 Jun; 55(6):728-31. PubMed ID: 7383460
[TBL] [Abstract][Full Text] [Related]
34. Natural killer cell activity in patients with abnormalities of the uterine cervix.
Neill W; Norval M
Gynecol Obstet Invest; 1984; 18(3):122-8. PubMed ID: 6092242
[TBL] [Abstract][Full Text] [Related]
35. The difference of the impacts of surgical approaches on cellular immunity in patients with uterine malignancies: a comparative study of laparoscopy and laparotomy surgery.
Zhang N; Liu H; Zhang Z; Wang S; Guo S
Gynecol Obstet Invest; 2011; 71(3):177-82. PubMed ID: 21160142
[TBL] [Abstract][Full Text] [Related]
36. Reaction of antigens isolated from herpes simplex virus-transformed cells with sera of squamous cell carcinoma patients.
Notter MF; Docherty JJ
Cancer Res; 1976 Dec; 36(12):4394-401. PubMed ID: 187320
[TBL] [Abstract][Full Text] [Related]
37. Antibody-dependent cell-mediated cytotoxicity to herpes simplex virus type 2 infected target cells in the course of cervical carcinoma.
Christenson B
Am J Epidemiol; 1978 Aug; 108(2):126-35. PubMed ID: 101081
[TBL] [Abstract][Full Text] [Related]
38. Prospective studies of the association of genital herpes simplex infection and cervical anaplasia.
Nahmias AJ; Naib ZM; Josey WE; Franklin E; Jenkins R
Cancer Res; 1973 Jun; 33(6):1491-7. PubMed ID: 4352387
[No Abstract] [Full Text] [Related]
39. Possible role of Herpesvirus hominis, type 2, in human cervical cancer.
Aurelian L
Fed Proc; 1972; 31(6):1651-9. PubMed ID: 4351374
[No Abstract] [Full Text] [Related]
40. Inhibition of colony formation by cytotoxic antibodies in cervical epidermoid carcinoma.
Byfield JE; Weintraub I; Klisak I; Lagasse LD
Radiology; 1973 Jun; 107(3):685-6. PubMed ID: 4735695
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
